Because delays or lags in the time it takes a clinical investigational site to activate a clinical trial can have a direct impact on the provision of state-of-the-art care to patients, University of Texas Southwestern (UTSW) Medical Center, a National Cancer Institute (NCI)-designated cancer center, led an investigation into the clinical trials activation process at the institution. After identifying 66 steps with 12 decision points to active one clinical trial, the team was able to streamline and simplify what is planned to be a more streamlined and accelerated process.
Clinical Trial Activation Time of Paramount Interest
Accelerating clinical trials in major academic medical centers is of paramount interest. These incredibly important institutions drive important clinical research; however, they are known to struggle with bureaucracy, politicized culture, and incoherent silos that, all together, slow down the clinical trials activation process. This hurts research and can take a direct toll on patients. For example, in oncology trials, where very sick cancer patients—potentially terminally ill—participate in new Phase I experimental medicines. Here at TrialSite News, we kn...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).